baber/WOPTO huggingface dataset:
Patent MX-PA02005611-A (MX)
Title: Method of preparing modified polyester bottle resins.
Inventor: SCHIAVONE ROBERT JOSEPH
IPC: B29L22/00
Filed: 2000-11-28
Abstract: The present invention is a method of preparing a high molecular weight copolyester bottle resin that has excellent melt processing characteristics. The method includes the steps of reacting a diacid or diester component and a diol component to form modified polyethylene terephthalate, wherein diol component is present in excess of stoichiometric proportions. Together, the diacid or diester component and the diol component must include at least 7 percent comonomer. The remainder of the diacid component is terephthalic acid or dimethyl terephthalate and the remainder of the diol component is ethylene glycol. The modified polyethylene terephthalate is copolymerized in the melt phase to an intrinsic viscosity of between about 0.25 dl g and 0.40 dl g to thereby form a copolyester prepolymer. Thereafter the copolyester prepolymer is polymerized in the solid phase to form a high molecular weight bottle resin that has an intrinsic viscosity of at least about 0.70 dl g, and a solid phase density of less than 1.413 g cc.
Patent MX-PA02006590-A (MX)
Title: 4phenyl1piperazinyl, piperidinyl and tetrahydropyridyl derivatives.
Inventor: KEHLER JAN
IPC: C07D295/073
Filed: 2000-12-22
Abstract: The present invention relates to substituted 4phenyl1piperazinyl derivatives having formula (I), wherein W is C, CH or N, and the dotted line emanating from W indicates a bond when W is C and no bond when W is N or CH; R1 and R2 are independently selected from hydrogen and halogen, provided at least one of R1 and R2 is a halogen atom; X is CH2, O, S, CO, CS, SO or SO2; and Q is a group of formula (II) provided that X is not O or S when the group Q is attached via an N atom; and any of its enantiomers and acid addition salts thereof. These compounds have high affinity for D4 receptors.
Patent MX-PA02006682-A (MX)
Title: Hair styling method.
Inventor: YAMASHITA YUKO
IPC: A45D44/00
Filed: 2001-01-05
Abstract: A designing method for treating hair according to the model paper of numerical or coded data on the hair design desired by the customer, realizing the hair style desired by the customer more properly than conventional hair treating methods and reproducing the hair style reliably, a styling method, and a design model are disclosed. Values andor symbols corresponding to the hair design desired by the customer are put on each segment of a development of a head, and the hair is designed according to the values, performing cutting, perming, and coloring according to the design.
Patent MX-PA02006885-A (MX)
Title: Nogo receptormediated blockade of axonal growth.
Inventor: STRITTMATTER STEPHEN M
IPC: C07K19/00
Filed: 2001-01-12
Abstract: Disclosed are Nogo receptor proteins and biologically active Nogo (ligand) protein fragments. Also disclosed are compositions and methods for modulating the expression or activity of the Nogo and Nogo receptor protein. Also disclosed are peptides which block Nogomediated inhibition of axonal extension. The compositions and methods of the invention are useful in the treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease.
Patent MX-PA02010434-A (MX)
Title: Low-pressure carburising method.
Inventor: GOLDSTEINAS AYMERIC
IPC: C23C8/22
Filed: 2002-02-22
Abstract: The invention relates to a low-pressure carburising method comprising alternating low-pressure enrichment steps and diffusion steps in the presence of a neutral gas. During the enrichment steps, an enriching gas and neutral gas mixture is used, the proportion of the neutral gas being between 5 and 50 % by volume of the enriching gas. The enriching gas can be, for example, acetylene (C2H2).
Patent MX-PA02010465-A (MX)
Title: Pneumovirus ns proteins antagonising the interferon (ifn) response.
Inventor: CONZELMANN KARL-KLAUS
IPC: A61K35/76
Filed: 2001-04-26
Abstract: The present invention relates to the use of a pneumovirus NS1 protein and/or NS2 protein or a nucleic acid encoding pneumovirus NS1 protein and/or NS2 protein for the preparation of a pharmaceutical formulation for reducing the immune response mediated by interferon (IFN). The invention further relates to recombinant pneumoviruses, in particular respiratory syncytial viruses (RSV), having an increased, reduced, or lacking a resistance to the interferon (IFN) mediated immune response, recombinant viruses having an increased resistance to the interferon (IFN) mediated immune response, and the use of the viruses in pharmaceutical applications, e.g. as vaccines.
Patent MX-PA03000329-A (MX)
Title: Low activity nuclear density gauge.
Inventor: DEP W LINUS
IPC: G01T1/36
Filed: 2003-01-10
Abstract: A nuclear density gauge and test method is provided for measuring density material in a relatively thin zone beneath a surface of the material. The gauge comprises a gauge housing and a substantially planar base on said gauge housing adapted to be positioned on a surface of the material sample. A gamma radiation source having a characteristic primary energy and an activity of no more than 100 microcurie is mounted within the housing and cooperates with the base for emitting gamma radiation through the base and into an underlying material sample. An energy selective gamma radiation detector is mounted within the gauge housing and in laterally spaced apart relation from the gamma radiation source. The gamma radiation detector is operable for quantifying the energy level of the detected gamma radiation. Shielding is provided within the gauge housing between the source and the detector for preventing gamma radiation from passing directly from said source to the detector. An analyzer is co nnected to the detector for detecting gamma radiation counts in a predetermined energy spectrum having a lower limit of 0.1 MeV or greater and an upper limit which is less than the characteristic primary energy of said source. The density of the sample is calculated based upon the gamma radiation counts obtained by the analyzer within the predetermined energy spectrum.
Patent MX-PA03000887-A (MX)
Title: Fused heterocyclic derivatives as phosphodiesterase inhibitors.
Inventor: SAWYER JASON SCOTT
IPC: C07D471/14
Filed: 2001-07-09
Abstract: Compounds of general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents.
Patent MX-PA03001772-A (MX)
Title: Vascular filter system for carotid endarterectomy.
Inventor: WELCH JEFFREY
IPC: A61M25/10
Filed: 2003-02-26
Abstract: A removable vascular filter system for capture and retrieval of emboli while allowing continuous perfusion of blood during a carotid endarterectomy procedure, comprising a porous filter membrane with variable diameter holes, and a filter membrane support structure. The system may minimize the incidence of stroke, or other clinical complications that may be associated with carotid endarterectomy procedures.
Patent MX-PA03005672-A (MX)
Title: Method and composition for the treatment of diabetic neuropathy.
Inventor: RICHARD A ROSENBLOOM
IPC: A61K45/06
Filed: 2001-12-19
Abstract: Compositions and a method for the treatment of diabetic neuropathy are disclosed. The compositions comprise a mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant, optionally formulated in a pharmaceutically acceptable carrier. This combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In addition, the compositions of the present invention, when used in effective amounts to treat diabetic neuropathy, do not exhibit the severe side effects of many prior art compositions proposed for treatment of this ailment. In a second aspect, a method for the administration of a composition in accordance with the present invention for the treatment of diabetic neuropathy is disclosed. In the method, an effective amount of the composition of the invention is administered over a period of time sufficient to provide the beneficial effects of relief from the symptoms of diabetic neuropathy, as well as at least some recovery of the damaged nerve tissues.
Patent MX-PA03007415-A (MX)
Title: Liquid epoxy resin emulsions, method for the production and use thereof.
Inventor: SASCHA TOEDTER-KOENIG
IPC: H01B3/40
Filed: 2002-02-06
Abstract: The invention relates to novel liquid epoxy resin emulsions which contain the following components, dissolved and/or dispersed in water: (A) at least one binding agent selected from the group made of epoxy resins and modified epoxy resins,(B) at least one non ionic thickener and (C) at least one catalyst for hardening, produced by reacting at least one boron trifluoride complex with at least one compound containing at least one epoxy group. The invention also relates to a method for the production and use thereof as an impregnating varnish for electrotechnical components, particularly for electrical winding items.
Patent MX-PA03008935-A (MX)
Title: Methods of fabricating nanostructures and nanowires and devices fabricated therefrom.
Inventor: ARUN MAJUMDAR
IPC: G02B6/10
Filed: 2002-03-29
Abstract: One-dimensional nanostructures having uniform diameters of less than approximately 200 nm. These inventive nanostructures, which we refer to as nanowires, include single-crystalline homostructures as well as heterostructures of at least two single-crystalline materials having different chemical compositions. Because single-crystalline materials are used to form the heterostructure, the resultant heterostructure will be single-crystalline as well. The nanowire heterostructures are generally based on a semiconducting wire wherein the doping and composition are controlled in either the longitudinal or radial directions, or in both directions, to yield a wire that comprises different materials. Examples of resulting nanowire heterostructures include a longitudinal heterostructure nanowire (LOHN) and a coaxial heterostructure nanowire (COHN).
Patent MX-PA03010498-A (MX)
Title: Process for the preparation of imipenem.
Inventor: YATENDRA KUMAR
IPC: C07D477/20
Filed: 2002-05-15
Abstract: The present invention relates to an improved, cost effective and industrially advantageous process for the preparation of imipenem.
Patent MX-PA03011806-A (MX)
Title: Improved catalytic reforming process.
Inventor: PARSONS JOHN S
IPC: B01J23/90
Filed: 2001-06-20
Abstract: A substantially water-free hydrocarbon feed is charged to a reformer reactor operated under reforming conditions, thereafter, a chlorine-containing additive is introduced, without the simultaneous introduction of water, into the substantially water-free hydrocarbon feed being charged to the reformer reactor in an amount and for a time period that are effective to inhibit deactivation of the reformer catalyst; thereafter, the introduction of the chlorine-containing additive is terminated and the charging of the substantially water-free hydrocrbon feed to the reformer reactor is continued.
Patent MX-PA04000613-A (MX)
Title: (pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators.
Inventor: MARCUS F BOEHM
IPC: A61P17/02
Filed: 2002-07-18
Abstract: The present invention relates to a method of modulating retinoid X receptor activity in a mammal, novel compounds and pharmaceutical compositions for modulating retinoid X receptor activity in a mammal, and methods of making compounds that modulate retinoid X receptor activity in a mammal. The compounds are represented by Structural Formula I: The compounds of Structural Formula I are efficacious insulin sensitizers and do not have the undesirable side effects of increasing triglycerides or suppressing the thyroid hormone axis.
Patent MX-PA04000824-A (MX)
Title: Reversible latch bolt.
Inventor: CHRIS HODGIN
IPC: E05C1/08
Filed: 2004-01-27
Abstract: A latch is provided for a mortise lock of the type comprising a housing for accommodating the lock components. The latch comprises a first and second portions movably mounted in the housing and a securing element for releasably connecting the first and second portions in either a first relative axial position or a second relative axial position where the first and second portions of the latch are rotatable relative to one another. In the first axially connected position of the latch, the first and second portions of the latch are movable together relative to the housing so that the first portion at least partially non-rotatably projects outwardly from the opening in the housing in an extended position of the latch, and the first portion is inside the housing in a retracted position of the latch. In the second axially connected position of the latch, the first portion of the latch extends further outwardly from the opening in the housing so that the first portion is rotatable relative to the housing and the first portion may be rotated to a selected position and returned to the first axially connected position of the first and second portions of the latch.
Patent MX-PA04001356-A (MX)
Title: Soy-based methyl ester high performance metal working fluids.
Inventor: NEIL M CANTER
IPC: C10M143/06
Filed: 2002-08-13
Abstract: The inventive composition comprises compatible combinations of methyl esters of fatty acids or triglycerides and polar non-chlorine extreme pressure additives, the composition being either (a) a working strength straight oil, (b) a soluble oil concentrate dilutable to a working strength soluble oil, the composition when at working strength effectively lubricating metal parts during high performance metalworking, and providing environmental and safety advantages.
Patent MX-PA04002401-A (MX)
Title: Novel medicaments for inhalation.
Inventor: RAINER SOYKA
IPC: A61K47/26
Filed: 2002-09-06
Abstract: The invention relates to novel medicament compositions based on tiotropium salts and poorly soluble salmeterol salts. The invention also relates to a method for the production of said compositions and to the use thereof for treating diseases of the respiratory tract.
Patent MX-PA04002457-A (MX)
Title: Systems and methods for monitoring terrestrially reused satellite frequencies to reduce potential interference.
Inventor: PETER D KARABINIS
IPC: H04W16/02
Filed: 2002-08-05
Abstract: Radiation by an ancillary terrestrial network, and/or satellite radiotelephones (120a, 120b) that communicate therewith are monitored and controlled, to reduce and preferably prevent intra-system interference and/or interference with other satellite radiotelephone systems. In particular, a satellite radiotelephone system includes a space-based component (110) that is configured to wirelessly communicate with first radiotelephones in a satellite footprint over a satellite radiotelephone frequency band (fD, fU), and an ancillary terrestrial network that is configured to wirelessly communicate with second radiotelephones in the satellite footprint over at least some of the satellite radiotelephone frequency band (f'D, f'U), to thereby terrestrially reuse the at least some of the satellite radiotelephone frequency band.
Patent MX-PA04006866-A (MX)
Title: Spatial field effect physical therapy device.
Inventor: ZHENG JIBING
IPC: A61N1/10
Filed: 2003-01-14
Abstract: A spatial field effect physical therapy device, including a base and (64) equidistant Yijing columns fitted on the base in the form of a square by (8) rows and (8) columns, each Yijing column is at a height of (2) to (18) unit length, in the rectangle consisted of arbitrary (4) Yijing columns, the sums of the heights of the Yijing columns at the ends of each diagonal of the rectangle is equal to each other. This spatial field effect physical therapy device needn't an incoming energy and is able to cure pains in human body effectively.
Patent MX-PA04010707-A (MX)
Title: Methods and apparatus for the communication of cellular network information between a wireless local area network and a mobile station.
Inventor: ADRIAN BUCKLEY
IPC: H04W12/06
Filed: 2004-10-28
Abstract: Methods and apparatus for the communication of cellular network informati on between a wireless local area network (WLAN) and a mobile station are disclosed. In one illustrative example, the mobile station receives a generic container messag e from the WLAN in an extensible authentication procedure (EAP). The generic container message includes cellular network information associated with one or more available cellular networks previously received by the WLAN. The generic container message is n ot technology or standard-specific and therefore it may contain cellular networ k information from a variety of different cellular networks (e.g. 3GPP, 3GPP2, IETF, etc.) . The mobile station decodes the generic container message to identify and store the cellular network information in its memory. Preferably, the cellular network information includes information for identifying the cellular networks so that the mobile station may appropriately select one of the cellular networks for communication.
Patent MX-PA04011740-A (MX)
Title: Protective cover for a comforter.
Inventor: WIRTZ JOSE
IPC: B65D85/00
Filed: 2003-04-30
Abstract: The invention relates to a protective cover (1) for a comforter, comprising a bottom face (1A) and a top face (1B) which form a flexible woven fabric envelope. The inventive cover is characterized by the fact that it is in the form of a single-piece envelope comprising an edge (2A) which is at least partly closed in a permanent manner and three edges (2B, 2C, 2D) which are provided with fast opening and closing means (3, 4, 5A, 5B) allowing the two faces (1A, 1B) of the envelope to be partly separated in order for the comforter to be placed on one (1A) of said faces (1A, 1B) of the envelope, whereupon the comforter is covered by the other face (1B) and at least two edges (2B, 2D) of said faces (1A, 1B) are joined with the aid of the fast opening and closing means (3).
Patent MX-PA05000220-A (MX)
Title: Closure plate lockout for a curved cutter stapler.
Inventor: WUKUSICK PETER
IPC: A61B17/00
Filed: 2005-01-03
Abstract: A surgical instrument is adapted for applying a plurality of surgical fasteners to body tissue. The surgical instrument includes an anvil and a cartridge housing containing a plurality of surgical fasteners. The cartridge housing and anvil are relatively movable between a first spaced apart position and a second closed position. A firing mechanism is associated with the cartridge housing for ejecting the surgical fasteners from the cartridge housing to be driven against the anvil. A lockout mechanism interacts with the cartridge housing for activation and deactivation; the lockout mechanism preventing movement of the cartridge housing to its second closed position but permitting relative reapproximation movement of the cartridge housing and anvil, whereby reapproximation provides an indicator that the instrument is not malfunctioning.
Patent MX-PA05002574-A (MX)
Title: Pyrazolopyrimidines as cyclin dependent kinase inhibitors.
Inventor: JAMES RAY ANTHONY
IPC: C07D487/04
Filed: 2003-09-03
Abstract: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
Patent MX-PA05002928-A (MX)
Title: Multi-layer braided structures for occluding vascular defects.
Inventor: GARY A THILL
IPC: A61B17/00
Filed: 2005-03-16
Abstract: A collapsible medical device and associated methods of occluding an abnormal opening in, for example, a body organ, wherein the medical device is shaped from plural layers of a heat-treatable metal fabric. Each of the fabric layers is formed from a plurality of metal strands and the assembly is heat-treated within a mold in order to substantially set a desired shape of the device. By incorporating plural layers in the thus-formed medical device, the ability of the device to rapidly occlude an abnormal opening in a body organ is significantly improved.
Patent MX-PA05004824-A (MX)
Title: 1,2,4-thiadiazole compounds and use thereof.
Inventor: HIDEKI IHARA
IPC: C07D285/125
Filed: 2002-11-08
Abstract: 1,2,4-Thiadiazole compounds represented by the general formula (1) have excellent control activities against injurious arthropods: (1) wherein R1 is C3-7 alkynyl which may be halogenated; R2 is halogeno, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, C1-4 alkylthio, cyano, or nitro, and n is an integer of 0 to 5, with the proviso that when n is an integer of 2 or above, R2s may be the same or different from each other; A is oxygen, sulfur, a single bond, CR3R4, or NR5; R3 and R4 are each independently hydrogen or C1-4 alkyl; and R5 is hydrogen or the like.
Patent MX-PA05004927-A (MX)
Title: Controlled release depot formulations.
Inventor: LOTHAR KLEINER
IPC: A61K47/34
Filed: 2003-11-04
Abstract: Methods and compositions for systemically or locally administering a beneficialagent to a subject are described, and include, for example, depot gel compositions that can be injected into a desired location and which can provide controlled release of @beneficial agent over a prolonged duration of time. The compositions include a biocompatiNe polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent.
Patent MX-PA05005748-A (MX)
Title: Tufted laminate web.
Inventor: JOHN JOSEPH CURRO
IPC: A61F13/15
Filed: 2003-12-16
Abstract: An absorbent article comprising a topsheet, a backsheet, and an absorbent core disposed between the topsheet and the backsheet is disclosed. The topsheet has a first side and a second side, the first side being a body-facing side and the second side being in fluid communication with the absorbent core. The topsheet also has a first relatively hydrophobic component and a second relatively hydrophilic component, the relatively hydrophilic component extending through the relatively hydrophobic component and being disposed on both of the sides of the topsheet. The absorbent article exhibits a rewet value of less than about 94 mg, and a fluid acquisition rate of at least about 0.10 ml/sec when tested by the Gush Acquisition and Rewet Test Method.
Patent MX-PA05006479-A (MX)
Title: Double cross parallel binder fabric.
Inventor: MONIQUE FAGON
IPC: D21F1/00
Filed: 2003-12-15
Abstract: A multi-layer fabric (100) which may be utilized in a papermaking process. Such fabric has a first layer (14) having machine direction (MD) yarns and cross-direction (CD) yarns interwoven therewith and a second layer (16) having machine direction (MD) yarns and cross-direction (CD) yarns interwoven therewith. In such fabric, a plurality of pairs of first type of binders (8) each having a first binder (10) and a second binder (12) are interwoven with the first (14) and second (16) layers. The first and second binders (10, 12) of at least one pair are interwoven with the first and second layers so as to pass over at least one same yarn on an outer surface of the first layer.
Patent MX-PA05008730-A (MX)
Title: Indazolamides with analgesic activity.
Inventor: LORENZO POLENZANI
IPC: C07D401/12
Filed: 2004-01-26
Abstract: An indazolamide (I), wherein X, R1, R2, R3, R4, R5, R6, R7 and R8 have the meanings given in the description, and addition salts thereof with a pharmaceutically acceptable acid, a method for the preparation thereof and a pharmaceutical composition containing the same.